![]() |
市場調查報告書
商品編碼
1324320
到 2030 年醫用工程材料的市場預測 - 按類型、用途和地區分類的全球分析Medical Engineered Materials Market Forecasts to 2030 - Global Analysis By Type (Medical Adhesives, Medical Foams, Medical Plastics, Medical Elastomer, Medical Films and Other Types), Application and By Geography |
根據Stratistics MRC預測,2023年全球醫療工程材料市場規模將達到230.2億美元,預計在預測期內將以14.6%的年複合成長率成長,到2030年達到597.7億美元。
醫療產品和服務(例如消耗品、設備和其他物品)是在稱為醫療工程材料 (MEM) 的材料的幫助下製造的。這些零件設計用於醫療設備製造、施工和安全。這些是高價值材料,其性能始終優於標準材料,從而帶來更輕的產品、更寬的溫度範圍、多種用途或在整個使用壽命內改進的性能。
總部位於瑞士的政府機構世界衛生組織 (WHO) 表示,到 2020 年,慢性病的盛行率預計將上升 57%。
奈米工程組件可用於創建心室的微型模型並治療與心臟相關的疾病。醫療設備中對工程材料的需求是由人口變化所驅動的,包括人口高齡化和新的疾病菌株。在全球範圍內,人口高齡化正在對產品設計和生產產生重大影響。在醫療保健領域,世界各地正在投入大量資金來升級設施和開發最先進的設備。因此,慢性疾病患者數量的增加正在刺激市場的擴大。
醫療廢棄物屬於含有傳染性成分的廢棄物類別。它由獸醫診所、醫院、實驗室和醫學研究設施等醫療機構產生的排放結構。醫療產業產生的廢棄物中很大一部分是塑膠。一些拋棄式器械經過再處理後可以再次使用。然而,這些產品被丟棄是因為它們沒有充分淨化,有人擔心它們可能會引起感染疾病。儘管生產商開始收集塑膠,但市場面臨塑膠廢棄物的重大挑戰。
醫療設備和儀器的製造嚴重依賴人造材料。專為醫療用途設計的材料是專門為滿足特定設備的要求而製造的。可修改以滿足規格以提供包括生物可分解性、滲透性和抗菌特性等品質的產品的需求正在為市場的快速成長創造機會。在過去的十年中,合成材料在醫療行業的使用顯著增加。這些工程材料用於取代金屬、陶瓷和玻璃等傳統材料。
政府法規醫療保健設施的成本,以確保全民享有醫療保健設施。因此,醫療器材製造商和原料供應商將不得不控制成本。隨著成本的降低,這些公司的利潤率也隨之下降。全球醫療保健領域受到嚴格法規。醫療器材核准機構使用各種方法來評估產品性能和安全性,並在不同的時間內授予產品認證。市場抑制因素包括政府對醫療器材成本的控制、各種法規以及冗長的核准程序。
由於 COVID-19,對個人防護裝備 (PPE) 套件、口罩、窗簾和手套的需求增加。容量限制迫使醫療機構擴大基礎設施並使其現代化,以適應不斷成長的患者數量。不僅民眾對個人防護裝備和口罩的需求不斷增加,醫療保健產業的各個領域也對個人防護裝備和口罩的需求不斷增加。在大流行期間,患者照護系統、熱掃描儀和相關設備的成長速度都可能比其他醫療設備更快。呼吸器是對抗新冠病毒的重要武器,需要塑膠、黏劑和彈性體等原料的快速供應、充足且及時的物流支援以及法規的批准。
預計醫用塑膠領域將出現良好成長。醫用塑膠是用於製造拋棄式醫療用品和醫療設備的最常見的其他醫療工程材料。醫療拋棄式用品、儀器、用具和藥物輸送系統均由塑膠製成。開發中國家慢性病市場的開拓和醫療基礎設施的擴大預計將導致醫療器材市場的振興,從而刺激對醫用塑膠的需求。
預計醫療拋棄式用品領域在預測期內將出現最快的年複合成長率。用於生產拋棄式醫療用品和醫療器材的最常見的其他醫療工程材料是醫用塑膠。醫療拋棄式用品、儀器、用具和藥物輸送系統均由塑膠製成。開發中國家慢性病市場的開拓和醫療基礎設施的擴大預計將重振醫療器材市場,並有望提振市場需求。
由於快速擴張,預計亞太地區在預測期內將佔據最大的市場佔有率。生產藥品的製藥公司和醫療器材製造商被吸引到該地區。當前系統中基於價值的護理的變化、價值鏈上的生態系統合作夥伴關係、增加的研發以及醫療保健系統的數位化是醫療器材業務的關鍵促進因素。
預計歐洲在預測期內的年複合成長率最高。對更好的醫療設施的需求以及與生活方式相關的疾病的增加正在推動歐洲市場的發展。此外,該領域市場的快速擴張歸因於3D列印和數位化等新技術在醫療器材製造中的越來越多的使用。
According to Stratistics MRC, the Global Medical Engineered Materials Market is accounted for $23.02 billion in 2023 and is expected to reach $59.77 billion by 2030 growing at a CAGR of 14.6% during the forecast period. Medical products and services such as disposables, equipment, and other items are made with the help of materials known as medical engineered materials (MEM). These components are designed to be used in the manufacture, construction, and safety of medical equipment. These are high-value materials that always perform better than standard materials, resulting in lighter goods, greater service temperature ranges, multipurpose use, or improved performance over the course of their whole life.
According to the World Health Organization, a Switzerland-based government agency, chronic disease prevalence is expected to rise by 57% by the year 2020.
The nano engineered components can be utilized to create a tiny model of a heart chamber and treat heart-related conditions. The demand for engineered materials in medical devices is driven by shifting demographics, including the aging population and emerging disease strains. Globally, the aging population growth is significantly influencing product design and production. Significant expenditures are being made worldwide in the healthcare sector to upgrade the facilities and create cutting-edge equipment. Therefore, the rise in chronic disease cases is fueling the market's expansion.
Medical wastes fall under the category of waste with infectious elements. It comprises the trash produced by healthcare facilities such veterinary clinics, hospitals, labs, and facilities for doing medical research. A sizable portion of the trash produced in the medical industry is plastic. After reprocessing, several single-use gadgets can also be used again. However, these products are disposed of because of concern that they won't be sufficiently decontaminated and cause an infection. Although producers have begun recovering plastic, the market still faces significant challenges from plastic waste.
The production of medical equipment and devices heavily relies on engineered materials. Medically designed materials are created specifically to meet the requirements of a given equipment. Opportunities for the market to grow rapidly are being created by the demand for products that can be modified to meet specifications for providing qualities including biodegradability, radio-opacity, and antibacterial characteristics. In the past ten years, the medical industry has used synthetic materials far more frequently. In place of conventional materials like metals, ceramics, and glass are these designed materials.
Governments regulate healthcare facility costs to guarantee universal access to the facilities. As a result, producers of medical devices and suppliers of raw materials must keep costs under control. Along with cost reduction, this lowers these players' profit margins. The world's healthcare sector is heavily regulated. Medical device approval agencies use a variety of techniques to evaluate the performance and safety of their products and grant product clearance throughout a range of time frames. Some market restraints include government control over medical device costs, a variety of regulations, and drawn-out approval procedures.
Personal protective equipment (PPE) kits, masks, drapes, and gloves are in higher demand as a result of the COVID-19. Healthcare facilities have been forced to expand and modernize their infrastructure due to capacity limitations in order to accommodate the growing patient intake. All areas of the medical sector as well as the general public have a strong demand for PPE kits and masks. Patient care systems, thermal scanners, and related equipment will all increase more quickly than other medical devices during the pandemic. Ventilators are essential weapons in the fight against the corona virus, which necessitates a quicker supply of raw materials like plastics, adhesives, and elastomers as well as appropriate and prompt logistical support and regulatory approvals.
The medical plastics segment is estimated to have a lucrative growth. The most common type of other medically designed materials used in the production of disposable medical items and devices is medical plastics. Medical disposables, instruments, and tools, as well as medication delivery systems, can all be made of plastics. Growing chronic disease rates and expanding healthcare infrastructure in developing nations are anticipated to fuel the market for medical devices, which will likely fuel demand for medical plastics.
The medical disposables segment is anticipated to witness the fastest CAGR growth during the forecast period. The most common type of other medically designed materials used in the production of disposable medical items and devices is medical plastics. Medical disposables, instruments, and tools, as well as medication delivery systems, can all be made of plastics. Growing chronic disease rates and expanding healthcare infrastructure in developing nations are anticipated to fuel the market for medical devices, which will likely fuel demand for the market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the rapid expansion. Pharmaceutical enterprises that make drugs and manufacturers of medical equipment have found the area to be appealing. The value-based care changes in current systems, ecosystem partnerships along the value chain, increased R&D, and digitalization of the healthcare system are the primary drivers for the medical devices business.
Europe is projected to have the highest CAGR over the forecast period. The desire for better healthcare facilities and the increase in disorders linked to lifestyle are what are driving the European market. Additionally, the rapid expansion of the market in this sector is due to the rising use of new technologies like 3D printing and digitization in the manufacturing of medical equipment.
Some of the key players profiled in the Medical Engineered Materials Market include: Evonik, SABIC, BASF, 3M Company, Eastman Chemical Company, Huntsman Corporation, Koninklijke DSM N.V., Celanese Corporation, Teknor Apex Company, Ethicon Inc., DuPont, Solvay, DSM, Nitto Denko, Sekisui Chemical, Trelleborg AB and Covestro AG.
In February 2023, Covestro launches new ultra-durable material solution for healthcare and life sciences. Covestro, a leading producer of advanced polymers and high-performance plastics in the United States and around the world, developed Makrolon® 3638 polycarbonate.
In October 2022, Covestro has developed a proof-of-concept heat-resistant coating for use on mono-PE stand-up pouches made with SABIC® BOPE polymer. The coating facilitates the industrial-scale production of BOPE-based mono-material stand-up pouches on horizontal form-fill-seal (HFFS) lines.